Gain Therapeutics, Inc. (GANX) Financials

$2.64

north_east
$0.2 (8.2%)
Day's range
$2.42
Day's range
$2.7

GANX Income statement / Annual

Last year (2023), Gain Therapeutics, Inc.'s total revenue was $55,180.00, a decrease of 60.62% from the previous year. In 2023, Gain Therapeutics, Inc.'s net income was -$22.27 M. See Gain Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $55,180.00 $140,108.00 $164,994.00 $28,881.00 $41,301.00 $20,609.00
Cost of Revenue $80,382.00 $64,168.00 $7.16 M $2.26 M $0.00 $0.00
Gross Profit -$25,202.00 $75,940.00 -$7.00 M -$2.23 M $41,301.00 $20,609.00
Gross Profit Ratio -0.46 0.54 -42.42 -77.22 1 1
Research and Development Expenses $11.52 M $8.38 M $7.16 M $2.26 M $1.59 M $826,880.00
General & Administrative Expenses $10.79 M $9.54 M $6.83 M $1.25 M $555,165.00 $222,047.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $10.79 M $9.54 M $6.83 M $1.25 M $555,165.00 $222,047.00
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $22.31 M $17.92 M $13.99 M $3.51 M $2.14 M $1.05 M
Cost And Expenses $22.31 M $17.92 M $13.99 M $3.51 M $2.14 M $1.05 M
Interest Income $494,234.00 $375,357.00 $12,495.00 $3,637.00 $20,540.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $20,540.00 $0.00
Depreciation & Amortization $83,579.00 $64,168.00 $15,484.00 $9,592.00 $2,571.00 $741.00
EBITDA -$22.17 M -$17.78 M -$13.82 M -$3.47 M -$2.10 M -$1.03 M
EBITDA Ratio -401.77 -126.2 -83.36 -116.8 -49.2 -49.13
Operating Income Ratio -403.28 -126.88 -83.8 -120.48 -50.85 -49.9
Total Other Income/Expenses Net $64,888.00 $279,283.00 -$60,425.00 -$92,847.00 -$86,222.00 -$67,441.00
Income Before Tax -$22.19 M -$17.50 M -$13.89 M -$3.57 M -$2.19 M -$1.10 M
Income Before Tax Ratio -402.11 -124.89 -84.16 -123.69 -52.94 -53.17
Income Tax Expense $79,275.00 $92,976.00 $4,008.00 $5,386.00 $7,114.00 $9,781.00
Net Income -$22.27 M -$17.59 M -$13.89 M -$3.58 M -$2.19 M -$1.11 M
Net Income Ratio -403.54 -125.55 -84.19 -123.88 -53.11 -53.64
EPS -1.71 -1.48 -1.37 -0.3 -0.18 -0.19
EPS Diluted -1.71 -1.48 -1.37 -0.3 -0.18 -0.19
Weighted Average Shares Out $13.01 M $11.88 M $10.17 M $11.88 M $11.88 M $5.86 M
Weighted Average Shares Out Diluted $13.01 M $11.88 M $10.17 M $11.88 M $11.88 M $5.86 M
Link